about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

Roche-backed biotech re­fu­els with $40M to steer neu­ro­mus­cu­lar can­di­date to­ward late-stage tri­als

4 years ago
Financing

Nick Leschly beefs up his C-suite at 2sev­en­ty, hir­ing Bris­tol My­ers alum to lead clin­i­cal push for next-gen CAR-Ts

4 years ago
People

As Omi­cron rages, FDA clears Eli Lil­ly/Ab­Celler­a's new an­ti­body days af­ter $720M sup­ply deal

4 years ago
FDA+
Coronavirus

Lat­est news on Covid vac­cine de­lay for kids; Door slammed shut for Chi­na-on­ly da­ta; Er­ic Lan­der is out; Look­ing back ...

4 years ago
Weekly

On long hunt for off-the-shelf CAR-T, Cel­lec­tis woos biotech chief to be­come its CFO

4 years ago
People

Pas­cal So­ri­ot: As­traZeneca 'on track' to hit big $40B goal, cap­ping years-long turn­around cam­paign

4 years ago
Pharma

As­traZeneca picks win­ner in in­haled JAK 'bake-of­f' while sweep­ing Alex­ion drug out

4 years ago
R&D

In fi­nal analy­sis, J&J's un­der­dog vac­cine of­fers on­ly 52.9% pro­tec­tion against Covid-19

4 years ago
R&D
Coronavirus

Hal Bar­ron’s swan song as GSK R&D chief ends with a promise: The best is yet to come

4 years ago
R&D

Mer­ck KGaA en­lists lit­tle AI play­er on pro­tein de­grad­er dis­cov­ery

4 years ago
Deals
AI

Tak­ing on Big Phar­ma-sized in­di­ca­tions, tiny biotech claims ear­ly win in fat loss. Will it trans­late to di­a­betes, ...

4 years ago
R&D

'Very over sol­d': Biotech brags about PhII Alzheimer's da­ta, but ex­perts are un­der­whelmed

4 years ago
R&D

On the heels of ex­posé re­veal­ing 'de­mean­ing' con­duct, Er­ic Lan­der re­signs from White House­'s top sci­ence perch

4 years ago
People

With de­ci­sion loom­ing on J&J, Leg­end's CAR-T, an­a­lyst sees a new cham­pi­on emerg­ing in boom­ing BC­MA space

4 years ago
R&D

Er­ic Lan­der 'bul­lied and de­meaned' staff at White House sci­ence of­fice — in­ves­ti­ga­tion

4 years ago
People

R&D heads play phar­ma mu­si­cal chairs; Shat­tered block­buster dreams; Death of Aduhelm?; and more

4 years ago
Weekly

With fin­ish line in sight, Brig­gs Mor­ri­son steps aside from Syn­dax CEO seat, swaps role with long­time col­league

4 years ago
People

Cod­ed cal­en­dar in­vites, covert emails and delet­ed doc­u­ments: Pfiz­er sues ex-em­ploy­ees for al­leged­ly steal­ing trade ...

4 years ago
People
Pharma

J&J bets $40M cash on biotech's ADC tech and its bat­tle-test­ed CEO — with biobucks adding to $1B

4 years ago
Deals

Cash-strapped an­tibi­otics play­er En­ta­sis could go pri­vate with a small-dol­lar buy­out of­fer on the ta­ble

4 years ago
Deals

A win in Rett syn­drome? Not so fast — biotech shares slide amid con­cerns of last-minute tri­al changes

4 years ago
R&D

GSK grabs $1.25B cash and a cut of Gilead­'s megablock­buster Bik­tarvy sales as HIV ri­vals set­tle patent suit

4 years ago
Pharma

How UCB beat 2 oth­er bid­ders to land $1.9B buy­out of Zo­genix and its epilep­sy drug

4 years ago
Deals

Mar­tin Shkre­li-as­so­ci­at­ed com­pa­nies set­tle an­ti-com­pet­i­tive law­suit with in­sur­er for $28M

4 years ago
People
First page Previous page 37383940414243 Next page Last page
A service from the Financial Times